Related Experiment Videos
Artificial pulmonary surfactant inhibited by proteins
Journal of Applied Physiology (Bethesda, Md. : 1985)
|February 1, 1987
Summary
Airway proteins like fibrinogen and serum can significantly inhibit the surface activity of Surfactant TA. This interference affects lung function by altering surface tension dynamics.
Area of Science:
- Pulmonary physiology
- Biochemistry
- Surface chemistry
Background:
- Surfactant TA is crucial for maintaining lung function by reducing surface tension.
- Airway proteins can potentially interact with and alter the efficacy of pulmonary surfactants.
Purpose of the Study:
- To investigate the inhibitory effects of various proteins on the surface activity of Surfactant TA.
- To determine the dose-dependent relationship of protein inhibition on surfactant function.
Main Methods:
- Utilized a pulsating bubble surfactometer to assess surface activity.
- Tested concentrations of fibrinogen, human serum, albumin, and a 55,000-dalton serum protein.
- Evaluated inhibition at varying phospholipid concentrations (6.25 mg/ml and 1.25 mg/ml).
Main Results:
- Fibrinogen demonstrated the strongest inhibition, followed by human serum and the 55,000-dalton protein; albumin was the weakest inhibitor.
- Bilirubin significantly augmented inhibition when combined with human serum.
- Protein inhibitors at concentrations >1 mg/ml significantly affected adsorption rates and increased surface tension.
Conclusions:
- Proteins commonly found in the airways can substantially impair the surface activity of Surfactant TA.
- This interference has significant implications for lung mechanics and respiratory health.
- Understanding these interactions is vital for managing respiratory conditions involving altered surfactant function.